PRECIGEN, INC.

PGEN

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
PGEN
CIK0001356090
SIC2834
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupPharmaceutical Preparations

Contact

Address20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
Website precigen.com
Phone301-556-9900
CEOHelen Sabzevari
Employees190

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$31.60 million
Pre-Tax Income$-204.42 million
Net Income$-204.42 million
Net Income to Common$-383.42 million
EPS$-1.21
View All
Balance Sheet
Cash$7.48 million
Assets$138.63 million
Liabilities$118.39 million
Common Equity$20.24 million
Liabilities & Equity$138.63 million
View All
Cash Flow Statement
Calculations
NOPAT$-65.73 million
EBITDA$-198.12 million
Price to EarningsN/A
Price to Book$76.46
ROE-1145.42%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Spotlight On 3 Growth Companies With Strong Insider Stakes

The United States market has shown robust performance with a 1.2% climb in the last week and a remarkable 29% increase over the past year, alongside expectations for earnings to grow by 17% annually in the coming years. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business's operations and potential.

Article Link

Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference

Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the company will participate in two upcoming investor events.

Article Link

Precigen (PGEN): The Best Penny Stock to Buy for Long Term

Precigen, Inc. (NASDAQ:PGEN) is one of the 10 Best Penny Stocks to Buy for Long Term. On May 14, 2026, H.C. Wainwright raised the firm’s price target on Precigen, Inc. (NASDAQ:PGEN) to $11 from $10 and kept a Buy rating on the shares following the company’s Q1 report. The firm said PAPZIMEOS sales comfortably exceeded […]

Article Link

Earnings Beat: Precigen, Inc. (NASDAQ:PGEN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Precigen, Inc. ( NASDAQ:PGEN ) investors will be delighted, with the company turning in some strong numbers with its...

Article Link

3 Growth Companies With High Insider Ownership And Up To 71% Earnings Growth

In the last week, the United States market has stayed flat, yet it has seen a remarkable 25% increase over the past year with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its potential for continued success.

Article Link